These two areas are very similar and related and there are many companies will also be involved. The area is characterized by: large investment, long cycle, high profit margins. Large multinational companies such as General Electric, Siemens, Philips, at present, in most markets, especially in high-end, in a leading position; but we have seen a number of key personnel returning from overseas to the creation of new market, companies have found a foothold, the product has established a certain customer base at home and abroad, are gradually becoming a strong competitor.
Mindray is a leader worthy of them. Since its inception in 1991, Mindray has always been committed to for the clinical development and medical-x-ray machine manufacturing, product information and support to cover the life, clinical examination and reagents, digital ultrasound, radiography four major areas, to date, Mindray worldwide sales has been extended to more than 190 countries and regions. Followed by Goldman Sachs to help its successful listing, to achieve a qualitative leap, played a role in four areas: first, to help Mindray knocking on the door of international markets; second is to help improve corporate governance Mindray; third Mindray preparedness funds for emergency use; Fourth, financial institutions, prestigious and well-known resource in the enterprise can improve the listing of the stock market to improve the two level market performance. Otherwise, Mindray also exist, but it may just be a mediocre performance, slow-growing small companies, is today the second "Huawei" .
In the field of medical equipment and instrumentation, the longer growth period, it normally takes 10 or even more time to achieve a certain size, you need a strategic private equity investors are partners, have patience, ability to fight a protracted war, it should be good preparation for the long-term holders of the fund cycle is generally about 10 years may not be suitable for private equity partnership investments in this industry. Warburg Pincus invested early on in the Mariner was successful, but because of time constraints, have been forced to withdraw, although rewarding, but did not wait until it is listed in New York more times to achieve the return and regret. The introduction of strategic partners, will help medical device and instrumentation companies in the client introduction, market development and post-financing to achieve more with less.

本文由广州佳誉医疗器械有限公司编辑